HEPATOBLASTOMA
Clinical trials for HEPATOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HEPATOBLASTOMA trials appear
Sign up with your email to follow new studies for HEPATOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to fight tough childhood cancers
Disease control OngoingThis study tests a combination of two drugs, cobolimab and dostarlimab, in children and young adults (up to age 21) with advanced solid tumors like melanoma, brain tumors, and bone cancer. The goal is to find the safest dose and see if the treatment can shrink tumors. Participant…
Matched conditions: HEPATOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New hope for kids with rare cancers: targeted drug shows promise in trial
Disease control OngoingThis study tests a daily pill called cabozantinib in children and young adults (up to age 30) with rare cancers like sarcomas, Wilms tumor, and others that have come back or not responded to treatment. The drug works by blocking signals that help tumors grow and form blood vessel…
Matched conditions: HEPATOBLASTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:55 UTC
-
New hope for kids with liver cancer: chemo combo trial launches
Disease control OngoingThis study tests different combinations of chemotherapy drugs in children and young adults with liver cancer (hepatoblastoma or hepatocellular carcinoma). The goal is to see which combinations work best with surgery to stop tumor growth or shrink tumors. About 537 participants wi…
Matched conditions: HEPATOBLASTOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Apr 29, 2026 15:00 UTC